• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Not Available].

作者信息

Ding Meng, Zhou Wanqing, Chen Wenyuan, Mo Wenjing, Guo Xinyue, Li Yuhang, Ji Changwei, Liu Guangxiang, Diao Wenli, Guo Hongqian

机构信息

Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, Nanjing, China.

Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, China.

出版信息

Clin Transl Med. 2024 Feb;14(2):e1575. doi: 10.1002/ctm2.1575.

DOI:10.1002/ctm2.1575
PMID:38356436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867590/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/6b877ccfa1d4/CTM2-14-e1575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/3fb3f490c67a/CTM2-14-e1575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/18a1a5e624a5/CTM2-14-e1575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/35bfc097b8cd/CTM2-14-e1575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/6b877ccfa1d4/CTM2-14-e1575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/3fb3f490c67a/CTM2-14-e1575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/18a1a5e624a5/CTM2-14-e1575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/35bfc097b8cd/CTM2-14-e1575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/10867590/6b877ccfa1d4/CTM2-14-e1575-g004.jpg

相似文献

1
[Not Available].[无可用内容]
Clin Transl Med. 2024 Feb;14(2):e1575. doi: 10.1002/ctm2.1575.
2
Biomarkers in renal-cell carcinoma: building on clinical paradigms.
Lancet Oncol. 2018 Dec;19(12):1560-1561. doi: 10.1016/S1470-2045(18)30674-0. Epub 2018 Nov 8.
3
Contemporary Prognostic Model for Renal Cell Carcinoma: Is it Time for Biomarkers?肾细胞癌的当代预后模型：是时候引入生物标志物了吗？
Eur Urol. 2021 Jul;80(1):32-33. doi: 10.1016/j.eururo.2021.04.019. Epub 2021 Apr 30.
4
Novel Biomarkers in Chromophobe Renal Cell Carcinoma: Distinguishing it from its Mimics.嫌色性肾细胞癌中的新型生物标志物：将其与相似疾病相鉴别
Eur Urol. 2020 Jul;78(1):75-76. doi: 10.1016/j.eururo.2020.03.045. Epub 2020 Apr 21.
5
[Clinicopathological features of clear cell papillary renal cell carcinoma-like clear cell renal carcinoma].
Zhonghua Bing Li Xue Za Zhi. 2022 Jan 8;51(1):44-46. doi: 10.3760/cma.j.cn112151-20210530-00392.
6
A Molecular Marker for Eosinophilic Solid and Cystic Renal Cell Carcinoma.
Eur Urol. 2018 Oct;74(4):487-488. doi: 10.1016/j.eururo.2018.06.040. Epub 2018 Jul 17.
7
On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?转移性肾细胞癌的治疗中生物标志物：能否实现预后个体化？
Expert Rev Anticancer Ther. 2017 Feb;17(2):97-99. doi: 10.1080/14737140.2017.1269605. Epub 2016 Dec 20.
8
Biomarkers 101 - personalizing therapy for RCC.
Nat Rev Urol. 2020 Nov;17(11):601. doi: 10.1038/s41585-020-00380-x.
9
Current and Future Biomarkers in the Management of Renal Cell Carcinoma.当前和未来的肾细胞癌管理中的生物标志物。
Urol Clin North Am. 2023 Feb;50(1):151-159. doi: 10.1016/j.ucl.2022.09.003.
10
SUZ12P1 could serve as a prognostic biomarker for patients with renal clear cell carcinoma.
Asian J Surg. 2023 Sep;46(9):3975-3977. doi: 10.1016/j.asjsur.2023.04.012. Epub 2023 Apr 17.

引用本文的文献

1
tRNA-derived small RNA 3' tRF-Ala CGC obstructs NK cytotoxicity via cleavage of membrane protein MICA in colorectal cancer.tRNA衍生的小RNA 3'tRF-Ala CGC通过切割结直肠癌中的膜蛋白MICA来阻碍自然杀伤细胞的细胞毒性。
Front Immunol. 2025 Jul 14;16:1620550. doi: 10.3389/fimmu.2025.1620550. eCollection 2025.
2
TsRNA-49-73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer.TsRNA-49-73-Glu-CTC：非小细胞肺癌中一种有前景的血清生物标志物。
PLoS One. 2025 Mar 28;20(3):e0320187. doi: 10.1371/journal.pone.0320187. eCollection 2025.
3
tRF-3a-Pro: A Transfer RNA-Derived Small RNA as a Novel Biomarker for Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.

本文引用的文献

1
The biogenesis, mechanism and function of the tRNA-derived small RNA (tsRNA): a review compared with microRNA.tRNA衍生小RNA（tsRNA）的生物发生、机制及功能：与微小RNA的比较综述
Am J Cancer Res. 2023 May 15;13(5):1656-1666. eCollection 2023.
2
Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application.液体活检在肾细胞癌前沿的应用：技术分析与临床应用的最新进展。
Mol Cancer. 2023 Feb 21;22(1):37. doi: 10.1186/s12943-023-01745-7.
3
Epidemiology of Renal Cell Carcinoma: 2022 Update.肾细胞癌的流行病学：2022 年更新。
tRF-3a-Pro：一种源自转运RNA的小RNA，作为诊断乙型肝炎病毒相关肝细胞癌的新型生物标志物。
Cell Prolif. 2025 Feb 24:e70006. doi: 10.1111/cpr.70006.
4
Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis.用于结核病诊断的血清tRNA衍生小RNA生物标志物的鉴定
Emerg Microbes Infect. 2025 Dec;14(1):2459132. doi: 10.1080/22221751.2025.2459132. Epub 2025 Feb 6.
Eur Urol. 2022 Nov;82(5):529-542. doi: 10.1016/j.eururo.2022.08.019. Epub 2022 Sep 10.
4
tsRFun: a comprehensive platform for decoding human tsRNA expression, functions and prognostic value by high-throughput small RNA-Seq and CLIP-Seq data.tsRFun：一个通过高通量小 RNA-Seq 和 CLIP-Seq 数据解码人类 tsRNA 表达、功能和预后价值的综合平台。
Nucleic Acids Res. 2022 Jan 7;50(D1):D421-D431. doi: 10.1093/nar/gkab1023.
5
A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer.一类新型的tsRNA特征作为胰腺癌诊断和预后的生物标志物。
Mol Cancer. 2021 Jul 17;20(1):95. doi: 10.1186/s12943-021-01389-5.
6
PANDORA-seq expands the repertoire of regulatory small RNAs by overcoming RNA modifications.PANDORA-seq 通过克服 RNA 修饰来扩展调控性小 RNA 的 repertoire。
Nat Cell Biol. 2021 Apr;23(4):424-436. doi: 10.1038/s41556-021-00652-7. Epub 2021 Apr 5.
7
tsRNA signatures in cancer.tsRNA 特征与癌症。
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8071-8076. doi: 10.1073/pnas.1706908114. Epub 2017 Jul 10.
8
RNAhybrid: microRNA target prediction easy, fast and flexible.RNAhybrid：轻松、快速且灵活的微小RNA靶标预测工具
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W451-4. doi: 10.1093/nar/gkl243.
9
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.保守的种子配对，通常两侧是腺苷，表明数千个人类基因是微小RNA的靶标。
Cell. 2005 Jan 14;120(1):15-20. doi: 10.1016/j.cell.2004.12.035.